The text provides references to studies on adjuvant treatments for colon cancer, including the use of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab, bevacizumab, and 5-fluorouracil and leucovorin. The studies evaluate the effectiveness of these treatments in improving survival and response to chemotherapy in patients with resected stage III colon cancer.